Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,72 USD | +4,35% |
|
+6,56% | -40,00% |
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 3,94 mln. 3,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -66 mln. -61,52 mln. | Nettowinst (verlies) 2022 | -36 mln. -33,55 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 25,09 mln. 23,38 mln. | Nettoschuld 2022 | 6,71 mln. 6,26 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-0,74
x | K/w-verhouding 2022 |
-0,11
x | Werknemers | 18 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 95,63% |
Recentste transcriptie over Eloxx Pharmaceuticals, Inc.
1 dag | +4,35% | ||
1 week | +6,56% | ||
Lopende maand | +4,35% | ||
1 maand | -15,29% | ||
3 maanden | -29,41% | ||
6 maanden | -40,00% | ||
Lopend jaar | -40,00% |
![Extreem 0.6101](/images/extremecours_fleche.png)
![Extreem 0.515](/images/extremecours_fleche.png)
![Extreem 0.515](/images/extremecours_fleche.png)
![Extreem 0.4](/images/extremecours_fleche.png)
![Extreem 0.4](/images/extremecours_fleche.png)
![Extreem 0.4](/images/extremecours_fleche.png)
![Extreem 0.4](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01-11-20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01-05-14 |
Alan Walts
BRD | Director/Board Member | 64 | 01-04-21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
01-07-24 | 0,72 | +4,35% | 794 |
28-06-24 | 0,69 | 0,00% | 467 |
27-06-24 | 0,69 | 0,00% | 1 361 |
26-06-24 | 0,69 | -4,83% | 5 232 |
25-06-24 | 0,725 | +7,29% | 7 448 |
uitgestelde koers OTC Markets, 01 juli 2024 om 16:51 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-40,00% | 2,38 mln. | |
+15,82% | 122 mld. | |
+20,35% | 114 mld. | |
+18,14% | 25,71 mld. | |
-25,31% | 19,02 mld. | |
-21,18% | 15,83 mld. | |
-19,67% | 15,32 mld. | |
-46,87% | 14,88 mld. | |
+62,55% | 14,82 mld. | |
+6,34% | 14,1 mld. |